Who We Work For
| Pharma/biotech | CROs | |
|---|---|---|
|
|
|
"Others try and sell a Dedicated Research Centre model, but they don‘t really have one. Their problem is they have no direct control over those clinicians who do not focus solely on research. Only Synexus has clinicians who are doing trials full-time. They have a concentrated effort with no distraction from other things."
Alastair Macdonald, Study Program Director (Oncology/Infection), Clinical Research Region, Europe, AstraZeneca
Have more questions? Contact us for more information


